SCHEMBL7413396

SCHEMBL7413396

O=C1c2c(c(=O)[nH]c3ccccc23)CN1c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.43
KDM4E B2RXH2 5/20 0.42
ALDH1A1 P00352 3/20 0.42
PARP1 P09874 2/20 0.42
CYP1A2 P05177 2/20 0.42
MEN1 O00255 1/20 0.42
TNKS O95271 1/20 0.42
LMNA P02545 1/20 0.42
GPR3 P46089 1/20 0.42
BLM P54132 1/20 0.42
PMP22 Q01453 1/20 0.42
KMT2A Q03164 1/20 0.42
PARP15 Q460N3 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TNKS2 Q9H2K2 1/20 0.42
ROCK2 O75116 1/20 0.42
PDE9A O76083 1/20 0.41
MAPT P10636 3/20 0.41
MTHFD2 P13995 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7412672 0.88 MAPT (0.44) ADORA3KDM4EALDH1A1PARP1CYP1A2
SCHEMBL7409538 0.86 ADORA3 (0.50) ADORA3KDM4EALDH1A1MEN1LMNA
SCHEMBL7411802 0.84 ADORA3 (0.52) ADORA3KDM4EALDH1A1CYP1A2MEN1
SCHEMBL7413902 0.75 ADORA3 (0.50) ADORA3KDM4EALDH1A1MEN1LMNA
SCHEMBL7408875 0.73 ADORA3 (0.52) ADORA3KDM4EALDH1A1CYP1A2MEN1
SCHEMBL7415475 0.72 MAPT (0.49) ADORA3KDM4EALDH1A1PARP1CYP1A2
SCHEMBL30273066 0.67 CHRNA7 (0.55) ADORA3KDM4EALDH1A1PARP1CYP1A2
SCHEMBL14355018 0.67 KDM4E (0.57) KDM4EALDH1A1PARP1CYP1A2MEN1
SCHEMBL28132803 0.65 MAPT (0.71) KDM4EALDH1A1PARP1CYP1A2MEN1
SCHEMBL31179077 0.65 MAPK1 (0.68) KDM4EALDH1A1PARP1CYP1A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5604235-A DIAGNOSIS AND TREATMENT OF ANXIETY, SLEEP AND SEIZURE DISORDERS, BENZODIAZEPINE OVERDOSE; ENHANCEMENT OF MEMORY NEUROGEN CORPORATION (US) 1997-02-18 US claimed
US-5908932-A Certain pyrroloquinolinones; a new class of GABA brain receptor NEUROGEN CORPORATION (US) 1999-06-01 US disclosed
US-5604235-A DIAGNOSIS AND TREATMENT OF ANXIETY, SLEEP AND SEIZURE DISORDERS, BENZODIAZEPINE OVERDOSE; ENHANCEMENT OF MEMORY NEUROGEN CORPORATION (US) 1997-02-18 US disclosed
US-5243049-A Gamma-aminobutyric acid antagonist NEUROGEN CORPORATION (US) 1993-09-07 US disclosed